ÇѹæÄ¡·á ÈÄ Gefitinib(Iresa)º¹¿ëÀ¸·Î ÀÎÇÑ ºÎÀÛ¿ë È£ÀüµÈ ºñ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚ 1·Ê
One Case Study of a Non Small Cell Lung Cancer Patient Experiencing Gefitinib Adverse Effects Managed by Traditional Korean Medicine

´ëÇѾÏÇÑÀÇÇÐȸÁö 2012³â 17±Ç 1È£ p.9 ~ p.16

¹ÚÀç¿ì(Park Jae-Woo) - ´ëÀü´ëÇб³ µÐ»êÇѹ溴¿ø µ¿¼­¾Ï¼¾ÅÍ
ÀüÇüÁØ(Jun Hyung-Joon) - ´ëÀü´ëÇб³ µÐ»êÇѹ溴¿ø µ¿¼­¾Ï¼¾ÅÍ
Á¶Á¾°ü(Cho Chong-Kwan) - ´ëÀü´ëÇб³ µÐ»êÇѹ溴¿ø µ¿¼­¾Ï¼¾ÅÍ
ÀÌ¿¬¿ù(Lee Yeon-Weol) - ´ëÀü´ëÇб³ µÐ»êÇѹ溴¿ø µ¿¼­¾Ï¼¾ÅÍ

Abstract

Objective : The aim of this study is to evaluate the synergistic effects of Traditional Korean Medicine with Gefitinib chemotherapy on a non small cell lung cancer.

Methods : A 61 year-old male patient diagnosed with left non small cell lung cancer stage IIIb (T2aN0M1a) was admitted to East-West Cancer Center (EWCC) on Apr. 2012. He received Gefitinib chemotherapy since 20th June. 2011. He suffered from many complication like as skin toxicities, peripheral neuropathy, lassitude, diarrhea and so on. He was treated with Traditional Korean Medicine consisted of herbal medicine, acupuncture, and moxibustion. The symptoms were measured by Common Terminology Criteria for Adverse Events (CTCAE version 3.0) and visual analogue scale (VAS). Performance status was measured by Eastern Cooperative Oncology Group (ECOG).

Results : TKM consisting of acupuncture, moxibusion, herbal medicine significantly alleviated Gefitinib induced complication. Quality of life was also significantly improved.

Conclusion : This case study suggests that TKM would beneficial to adverse effects such as skin toxicities, peripheral neuropathy, lassitude from gefitinib.

Å°¿öµå

Non small cell lung cancer, Gefitinib, Traditional korean Medicine, adverse effect
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
TKM would beneficial to adverse effects such as skin toxicities, peripheral neuropathy, lassitude from gefitinib.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå